However, we are prepared to sell under the right circumstances. The Z-92 psoriasis treatment is a topical treatment for skin disease of psoriasis. It is made from a plant extract mixed with acetic acid. The plant is currently grown in Israel and can be annually harvested on an agricultural basis. Psoriasis is a noncontiguous skin disorder that most commonly appears as inflamed swollen skin lesions covered with silvery white scales.
Psoriasis comes in many different variations and degrees of severity.
In addition, our Z-92 psoriasis treatment is an acceptable form for a first generation product launch without the need for further significant formulation modifications. We have two issued domestic patents. Our PCT patents are pending in 26 foreign countries should be issued in the near future. We are at the advanced preclinical phase of the FDA process. We filed our Investigational New Drug Application in September 1999 with the FDA and it was accepted by the FDA in October.